From: Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
Characteristics | Entire set (n = 342) |
---|---|
N (%) | |
Age, years | |
≤ 60 | 141 (41.2%) |
> 60 | 201 (58.8%) |
Stage | |
I | 221 (64.6%) |
II | 31 (9.1%) |
III | 77 (22.5%) |
IV | 13 (3.8%) |
Grade | |
G1 | 80 (23.4%) |
G2 | 74 (21.6%) |
G3 | 188 (55.0%) |
Peritoneal wash | |
Negative | 293 (85.7%) |
Positive | 49 (14.3%) |
Person neoplasm cancer status | |
Tumor free | 291 (85.1%) |
With tumor | 51 (14.9%) |
Radiation therapy | |
Yes | 140 (40.9%) |
No | 202 (59.1%) |
Histological type | |
Endometrioid endometrial adenocarcinoma | 268 (78.4%) |
Serous endometrial adenocarcinoma | 61 (17.8%) |
Mixed serous and endometrioid | 13 (3.8%) |
Surgical approach | |
Minimally invasive | 150 (43.9%) |
Open | 192 (56.1%) |